缩写名/全名 |
CHEM BIOL DRUG DES
Chemical Biology & Drug Design |
||||||||||||||||||||||||||||||||
ISSN号 | 1747-0277 | ||||||||||||||||||||||||||||||||
研究方向 | 医学-生化与分子生物学 | ||||||||||||||||||||||||||||||||
影响因子 | 2015:2.802, 2016:2.396, 2017:2.328, 2018:2.256, 2019:2.548, | ||||||||||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||||||||||
年文章数 | 182 | ||||||||||||||||||||||||||||||||
出版年份 | 2006 | ||||||||||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||||||||||
审稿周期(仅供参考) | 平均5.0个月 |
||||||||||||||||||||||||||||||||
录用比例 | 约75% | ||||||||||||||||||||||||||||||||
投稿链接 | http://mc.manuscriptcentral.com/cbdd | ||||||||||||||||||||||||||||||||
投稿官网 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 | ||||||||||||||||||||||||||||||||
h-index | 71 | ||||||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1747-0277%5BISSN%5D | ||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Design, synthesis, and evaluation of a series of novel phenylpropanoic acid derivatives agonists for the FFA1. Author: Yang J1, Gu E1, Yan T2, Shen D1, Feng B1, Tang C1. Journal: Chem Biol Drug Des. 2019 May;93(5):900-909. doi: 10.1111/cbdd.13480. Epub 2019 Jan 29. PubMed DOI |
2. | Design, synthesis, and biological evaluation of 4-aminopyrimidine or 4,6-diaminopyrimidine derivatives as beta amyloid cleaving enzyme-1 inhibitors. Author: Xu X1, Lü P1, Wang J1, Xu F1, Liang L1, Wang C1, Niu Y1, Xu P1. Journal: Chem Biol Drug Des. 2019 May;93(5):926-933. doi: 10.1111/cbdd.13489. Epub 2019 Feb 12. PubMed DOI |
3. | A combined drug discovery strategy based on machine learning and molecular docking. Author: Zhang Y1, Wang Y1, Zhou W1, Fan Y1, Zhao J1, Zhu L1, Lu S1, Lu T1,2, Chen Y1, Liu H1. Journal: Chem Biol Drug Des. 2019 May;93(5):685-699. doi: 10.1111/cbdd.13494. Epub 2019 Mar 7. PubMed DOI |
4. | Synthesis and antitumor activity of 2-isocamphanyl thiosemicarbazone derivatives via ROS-enhanced mitochondria damage. Author: Wang Y1, Wang Z1, Kuang H1, Zhang Y1, Gu W1,2, Zhu Y3, Wang S1,2. Journal: Chem Biol Drug Des. 2019 Jan 28. doi: 10.1111/cbdd.13492. [Epub ahead of print] PubMed DOI |
5. | Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation. Author: Wang Y1,2, Peng C2, Wang G2, Xu Z2, Luo Y1, Wang J2, Zhu W2. Journal: Chem Biol Drug Des. 2019 May;93(5):934-948. doi: 10.1111/cbdd.13493. Epub 2019 Feb 19. PubMed DOI |
6. | Proteoliposome-based model for screening inhibitors targeting histidine kinase AgrC. Author: Zhang L1,2, Quan C1,2, Zhang X3, Xiong W1,2, Fan S1,2. Journal: Chem Biol Drug Des. 2019 May;93(5):712-723. doi: 10.1111/cbdd.13497. Epub 2019 Mar 13. PubMed DOI |
7. | Molecular design of sequence-minimized, structure-optimized, and hydrocarbon-stapled helix-helix interactions in the trimer-of-hairpins motif of pediatric pneumonia RSV-F protein. Author: Wang J1, Zhang J1, Sun X1, Liu C1, Li X1, Chen L2. Journal: Chem Biol Drug Des. 2019 Feb 18. doi: 10.1111/cbdd.13501. [Epub ahead of print] PubMed DOI |
8. | Computational insights into the interaction mechanisms of estrogen-related receptor alpha with endogenous ligand cholesterol. Author: Li D1, Cai Y1, Teng D1, Li W1, Tang Y1, Liu G1. Journal: Chem Biol Drug Des. 2019 Feb 27. doi: 10.1111/cbdd.13506. [Epub ahead of print] PubMed DOI |
9. | Design, Synthesis and Evaluation of Novel Heteroaryldihydropyrimidines Derivatives as Non-nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent-exposed Region. Author: Yu J1, Guo X2, Desta S1, Zhang S1, Zhang J1, Ding X1, Liang X2, Jia H3, Liu X1, Zhan P1. Journal: Chem Biol Drug Des. 2019 Mar 1. doi: 10.1111/cbdd.13512. [Epub ahead of print] PubMed DOI |
10. | Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch. Author: Chen L1, Li Q1, Zheng Z1, Xie J1, Lin X2, Jiang C1, Xu H1, Wu X1,3, Wu J1, Zhang H1. Journal: Chem Biol Drug Des. 2019 Mar 15. doi: 10.1111/cbdd.13514. [Epub ahead of print] PubMed DOI |
|
|